BR Biopharma (NASDAQ:BRBI) Trading Up 0.5% – Still a Buy?

BR Biopharma, Inc. (NASDAQ:BRBI)’s stock price rose 0.5% during mid-day trading on Friday . The company traded as high as $9.40 and last traded at $9.40. Approximately 1,520 shares traded hands during trading, an increase of 287% from the average daily volume of 393 shares. The stock had previously closed at $9.35.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised BR Biopharma from a “sell (e)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

BR Biopharma Stock Up 0.5%

The stock has a fifty day moving average price of $11.32.

BR Biopharma (NASDAQ:BRBI) last posted its earnings results on Tuesday, June 30th. The company reported $0.09 earnings per share (EPS) for the quarter. The company had revenue of $25.13 million for the quarter.

BR Biopharma Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Monday, August 17th will be given a dividend of $0.1415 per share. The ex-dividend date is Monday, August 17th. This represents a $0.57 dividend on an annualized basis and a yield of 6.0%.

Institutional Investors Weigh In On BR Biopharma

An institutional investor recently bought a new position in BR Biopharma stock. Acuitas Investments LLC acquired a new stake in shares of BR Biopharma, Inc. (NASDAQ:BRBI) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma comprises 3.2% of Acuitas Investments LLC’s portfolio, making the stock its 7th biggest holding.

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.